J. V. van Griensven

A cross-over comparison of the anti-clotting effects of three low molecular weight heparins and glycosaminoglycuronan.

A. Cohen, T. van Dinther, J. Stiekema, 1993, British journal of clinical pharmacology.

New polyurethane valves in new soft artificial hearts.

S. Hofma, W. Kolff, S. Topaz, 1989, ASAIO transactions.

The oral bioavailability of pentosan polysulphate sodium in healthy volunteers

A. Cohen, C. Kluft, J. Burggraaf, 1999, European Journal of Clinical Pharmacology.

On the Role of C1-Inhibitor as Inhibitor of Tissue-type Plasminogen Activator in Human Plasma

L. Huisman, C. Kluft, J. V. van Griensven, 1995, Thrombosis and Haemostasis.

Effect of Isotretinoin on Endogenous Tissue-Type Plasminogen Activator (t-PA) and Plasminogen Activator Inhibitor 1 (PAI-1) in Humans

T. Kooistra, W. Lambert, H. Schoemaker, 1993, Thrombosis and Haemostasis.

Effect of Changes in Liver Blood Flow on the Pharmacokinetics of Saruplase in Patients with Acute Myocardial Infarction

R. Schoemaker, A. Cohen, W. Günzler, 1997, Thrombosis and Haemostasis.

The effect of m-CPP on tics and obsessive-compulsive phenomena in Gilles de la Tourette syndrome

D. Cath, A. Cohen, H. Gijsman, 1999, Psychopharmacology.

Successful Electroconvulsive Therapy in a Patient With Catatonia and a Rare HIVEP2 Mutation.

A. Lachmeijer, H. V. van Mierlo, J. V. van Griensven, 2023, The journal of ECT.